Caplin Point Laboratories Limited has informed the Exchange regarding a press release dated May 05, 2026, titled "Receipt of final approval by our Subsidiary, Caplin Steriles Limited, from the USFDA for Calcium Gluconate Injection USP".
Press Release May 05 2026
Earlier from Caplin Point Laboratories
- Press Release Mar 13 2026
- Press Release Feb 28 2026
- Press Release Feb 24 2026
- Press Release Jan 27 2026
